Inhaled Medicine Improves Survival For Lung Transplant Patients

03/Feb/2006

An inhaled anti-rejection drug can dramatically improve survival after a lung transplant, according to a study conducted at the University of Pittsburgh and led by lung disease specialists who are now at the University of Maryland in Baltimore. The results of the study are published in the January 12, 2006 edition of the New England Journal of Medicine.